TRANSITIONAL CELL CARCINOMA
Clinical trials for TRANSITIONAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new TRANSITIONAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for TRANSITIONAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Bladder cancer drug cocktail shows promise in early trial
Disease control OngoingThis study tests a three-drug combination (ixazomib, gemcitabine, and doxorubicin) in people with advanced bladder cancer that has spread or cannot be surgically removed. The goal is to find the safest and most effective doses and see if the combination shrinks tumors. About 57 p…
Matched conditions: TRANSITIONAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 11:33 UTC
-
Immunotherapy duo takes on 50+ rare cancers in major trial
Disease control OngoingThis phase 2 trial tests a combination of two immunotherapy drugs (nivolumab and ipilimumab) in over 800 people with more than 50 types of rare cancers. The goal is to see if this treatment can shrink tumors by helping the immune system attack cancer cells. The study is for patie…
Matched conditions: TRANSITIONAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:54 UTC